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SUMMARY
We wondered whether anti-myeloperoxidase (MPO) autoantibodies (MPO-ANCA) found in
patients with systemic vasculitis react with a conformational epitope or epitopes on the MPO
molecule. Sera from 15 human MPO-ANCA, and a polyclonal and a monoclonal anti-MPO
antibodies were reacted with MPO in native and denatured states. Human MPO-ANCA and mouse
monoclonal anti-MPO reacted with native MPO, and a 120-kD band representing the MPO
hologenzyme, but not with denatured MPO fragments; however, MPO-ANCA and mouse anti-MPO
did not demonstrate competitive inhibition of binding to MPO. Polyclonal rabbit anti-MPO reacted
with both native and denatured MPO. All MPO-ANCA tested showed the same patterns of reactivity
with native and denatured MPO in dot blot and Western blot analyses. Both polyclonal and
monoclonal anti-MPO antibodies inhibited MPO's protein iodination by over 90%, whereas MPO-
ANCA IgGs, normal IgGs and disease control IgGs did not. These data suggest that (i) MPO-ANCA
interact with a conformational epitope on the MPO molecule; and (ii) MPO-ANCA from different
patients have similar reactivity with native versus denatured MPO.
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INTRODUCTION PATIENTS AND METHODS
Patients and sera
Anti-neutrophil cytoplasmic autoantibodies (ANCA) have Sera containing MPO-ANCA were obtained from patients with
been found in the circulation of patients with the most common pauci-immune necrotizing and crescentic glomerulonephritis
types of systemic necrotizing vasculitis, including microscopic with and without extra-renal vascular inflammation. Five of 11
polyarteritis nodosa, Wegener's granulomatosis, and Churg- patients had pulmonary capillaritis with alveolar haemorrhage;
Strauss syndrome [1-8]. There are two ANCA subtypes defined five had vasculitis involving the upper respiratory tract, nerves,
by indirect immunofluorescence microscopy staining patterns. or skin; and five patients had renal-limited disease. P-ANCA
Cytoplasmic pattern ANCA (CANCA), which are usually were identified using indirect immunofluorescence microscopy
specific for proteinase-3 [9-14], and perinuclear pattern ANCA and alcohol-fixed normal human neutrophils as described
(P-ANCA), which are usually specific for myeloperoxidase previously [2,17]. Patients with P-ANCA reactivity were tested
(MPG-ANCA) [1,3,13]. Both types of autoantibodies are by ELISA for reactivity with neutrophil cytoplasm extract and
capable of activating cytokine-primed neutrophils in vitro reactivity with purified MPO using previously described meth-'ods [1] All of the P-ANCA used in this study had anti-MPOinducing a respiratory burst and release of granule constituents sp[1]. All ofte P-ANCAu in this s y a anti-MPG
[14]. Therefore, ANCA may be directly involved in the pathoge-
nesis of necrotizing vascular inflammation, the anti-MPO ELISA of greater than 3 s.d. above the mean
We wondered whether MPO-ANCA from different patients obtained with 13 normal control sera.
reacted with the same or different portions of the myeloperoxi-
dase molecule, and whether this reactivity was directed at a Dot blots
conformational epitope [15] or at a primary structure epitope NircluoesipwredtdwthMG ihwihan-[16].rmational epitope [151 MPO antibody reactivity was to be analysed. Myeloperoxidase
was elther purchased from Calbiochem (San Diego, CA) or
isolated from purified azurophilic granules using a modification
Correspondence: Ronald J. Falk, MD, Department of Medicine, of the procedure of Matheson [18]. Reactivity of MPG-ANCA
Division of Nephrology, CD No. 7155, 3034 Old Clinic Bldg, Chapel and anti-MPG antibodies was evaluated after the MPG had
Hill, NC 27599, USA. been exposed to the following conditions: denaturation with 2%
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SDS, reduction with 2-6% beta-mercaptoethanol (B-ME), 1 2 3 4 5 6
combined chemical denaturation and reduction, and thermal A _
denaturation at 1000C for 2 min. One hundred nanograms of A l .
MPO was placed in each dot. The strips were washed in 150mM B
NaCl, 50 mm Tris pH 7-2 (TBS), blocked with 5% non-fat dry
milk for 2 h, and incubated with MPO-ANCA, polyclonal anti-c
MPO, or monoclonal anti-MPO. The strips were washed and
exposed to the appropriate secondary antibodies and alkaline D
phosphatase substrate. For staining of immunoblots, human
MPO-ANCA + serum was used at a dilution of 1:40. Polyclonal .,
rabbit anti-human MPG (Dako, Carpinteria, CA) was used at a F
dilution of 1:2000, and mouse monoclonal anti-human MPO 8
(Dako) was used at 1:500. Appropriate secondary antibodies)
included goat anti-rabbit IgG alkaline phosphatase conjugate H -: t
and 0 45 mMr 5-bromo-4-chloro-3-indolyl-phosphate (Sigma) in acidic buffered (2); denatured and boiled (3); denatured, reduced and
100 mBuTris, 100 mn sodium chloride, 5 m magnesium boiled (4); denatured and reduced, but not boiled (5); and denatured but
chloride buffer, pH 95. not boiled (6). Polyclonal rabbit anti-MPG reacted with MP under all
conditions (lane A). Mouse monoclonal anti-MPG recognized MPG in
Western blots its native state, but not when it was thermally denatured (lane B). Seven
Myeloperoxidase was run on 10% or 13% polyacrylamide MPg oANCA sera tested also reacted to MP in its native state, but not
electrophoresis with a 4% stacking gel. Before evaluating when it was thermally denatured (lanes C-I). Normal human sera did
reactivity with antibodies, MPG was exposed to the following not react with MPG (lane J).
conditions: denaturing conditions with 2% SDS; reducing
conditions with 2-6% B-ME; combined denaturing and affected by a non-specific protein effect so that the amount of
reducing conditions; and thermal denaturation by heating to IgG added was rigorously standardized. The following reagents
1000C for 2 mmi. were added in sequence: MPG, H2G2, MPG-ANCA IgG or
TransferoofrthesMPGwtoha p4 M nitrocellulose(Schleicher and polyclonal or monoclonal anti-MPG antibodies, and Nad25I.
Schuell, Keene, NH) was performed using a Mini-transblot cell The mixture was rotated for 30 mm at room temperature and the
(Biorad, Rockville Center, NY) with 10% methanol in Tris- reaction stopped with cold 5 6 mu sodium thiosulphate (Fisher,
glycine buffer pH 86 at 250 mA for I h [19]. Transfer of protein FairLawnf NJ), followed by the addition of20% trichloroacetic
was assessed by staining the nitrocellulose strips with amido acid (TCA) (EM, Cherry Hill, NJ) to precipitate the protein.
black. The nitrocellulose strips were washed in distilled water The pellet was repetitively washed with 10% TCA, centrifuged
and TBS, and blocked in 5% non-fat dry milk for 2 h The strips and then protein bound radioactivity was counted. The addition
were incubated in the different primary anti-MPG antibodies of Na azide served as the positive control for each assay while
overnight, washed in 5% non-fat dry milk three times, and the negative controls included assays performed without H2e2
incubated again in secondary antibody for 2 h. The reaction and without MPG. The monoclonal anti-MPG, polyclonal anti-
product was developed with alkaline-phosphatase developing MPG, MPG ANCA IgG, C-ANCA IgG and normal IgG were
buffer. used at a final concentration of2t04 ,ug/ml,0o762 g/ml,0t 1 mg/
ml or 0 025 mg/ml. Results were expressed as a percentage ofFunctional activity oflmyeloperoxidase inhibition compared to the inhibition observed with Na azide.
In order to assess whether MPo-ANCA could block MPG
function, protein halogenation by MPG in the presence of
MPG-ANCA was studied. Modification of a standard MPo RESULTS
protein halogenation assay [20,21] was designed as a cell-free Dot blot analysis
system. In this assay, 100 mU of MPG (Calbiochem), 0 1moMPG-ANCA sera were tested on dot blots for reactivity of the
Na'251 (New England Nuclear, Irvine, CA), and 0-1 mM human autoantibodies with MPG in its native form, treated
hydrogen peroxide (H2e2) (Sigma) were mixed in Hanks with acid denatured with SDS and/or reduced with B-ME, and
buffered saline solution with calcium and magnesium thermally denatured. For purposes of comparison, polyclonal
(HBSS++~) (137 mMs NaCJ, 137 mMs KCl, 352 mMs Na2HPG4, 441 rabbit anti MPG aswell asamonoclonalmouseanti-MPGwere
mM KH2PG4, with 12d 9 moi CaCl2.H2G) and 4ma tested. The polyclonal rabbit anti-MPG reacted with MPG
So4.7H2. Todefinethemaximumdegree ofinhibition,assays under all the conditions (Fig. 1, lane A). In contrast, the
were run with and without10 0 mo sodium azide (Sigma). The monoclonal anti-MPG did not react with thermally denatured
reaction was carried out in borosilicate glass tubes to which MPn but reacted with MPG in its native state, as well as when it
HBSSy + and heat-inactivated sera were added and incubated at was partially denatured with SDS or reduced with B-ME (Fig. 1,
37C. Because of the peroxidase activity of sera, purified IgG lane B)uSeven MPo-ANCA reacted in a fashion exactly the
was prepared as previously described [19]. The assay was also same as the MoAb, i.e. by not reacting with thermally denatured
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Fig. 2. By Western blot analysis, myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPG-ANCA) reacted with approximately 120-kD





1 2 3 Fig. 4. By Western blot analysis, human myeloperoxidase anti-neutro-
Fig 3. By Western blot analysis, polyclonal rabbit anti-myeloperoxidase phil cytoplasmic autoantibodies (MPG ANCA) (lanes 3, 4) and mouse
(MPG) reacted with all of the subunits of MPG obtained under monoclonal anti-MPG antibodies (lanes 1, 2) reacted in a very similar
thermally denaturing and reducing conditions (lane 1). In contrast, the fashion with MPG treated with SDS (lanes 1, 3), and MPG treated with
monoclonal anti-MPG antibody did not react with any of the MPG SDS and beta-mercaptoethanol (B ME) (lanes 2, 4). None of the MPG
subunits (lane 2), nor did any of the eleven MPG anti-neutrophil was thermally denatured. Normal serum (lane 5) was not reactive with
cytoplasmic autoantibodies (ANCA) (one representative sample, lane the SDS- and B-ME-treated MPG.
3).
Human MPG-ANCA and mouse monoclonal anti-MPG
reacted in a similar fashion on Western blots (Fig. 4). Both
MPGbutwit MP initsnatve tat an whn prtill reacted with partially denatured MPG, and with MPG that was
denaturedith SDS ( ig 1,lnsC * reduced but not thermally denatured. A doublet was observed
that was recognized by both monoclonal anti-MPG and MPG-
Western blot analysis ANCA (Fig. 4, lanes 2, 4).
By Western blot analysis 15 MPG ANCA reacted with an
approximately 120-kD band derived from SDS-treated MPG, Inhibition of myeloperoxidase function
but not with thermally denatured MPG. The degree of reactivity We determined whether MPG ANCA were capable of inhibit-
varied between samples (Fig. 2). The polyclonal rabbit anti- ing MPG functional activity by measuring MPG-induced
MPG antibody also reacted with an approximately 120-kD protein iodination in a cell-free assay. Purified immunoglobu-
band, and with all of the bands denived from thermally lins were prepared from MPG ANCA, C-ANCA, normal, and
denatured MPG (Fig. 3). Monoclonal mouse anti-MPG did not disease control sera. The polyclonal anti-MPG antibody in-
react with thermally denatured MPG (Fig. 3, lane 2), nor did any hibited MPG-induced protein iodination to the same extent as
of the MPG-ANCA (Fig. 3, lane 3). None of the control sera that observed for sodium azide (92% ± lO-2 (mean ± 2 s.d.)
reacted with the 120-kD band, nor any of the larger molecular n= 10) (Fig. 5). Monoclonal anti MPG was also able to inhibit
weight fragments of MPG; however, several control sera did protein iodination9[5%+7 4(mean+s.d.) (n=3). Incontrast,
react with undefined material that migrated at approximately 14 seven MPG-ANCA IgG, eight C ANCA IgG, seven normal
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MPO IgG IgG IgG
n = 10 n=7 n: 6 n=8
Fig. 5. Purified IgG preparations of myeloperoxidase anti-neutrophil
cytoplasmic autoantibodies (MPO-ANCA), C-ANCA, disease control
and normal human sera were tested for the ability to inhibit MPO
function. Polyclonal and monoclonal anti-MPO antibodies inhibited
MPO iodination ofprotein by 92%. In contrast, only 25-30% inhibition
of MPO activity was seen with MPO-ANCA IgG, C-ANCA IgG,
disease control IgG, and normal IgG. There were no differences in the
inhibition of MPO by MPO-ANCA IgG when compared with other
IgGs.
similar degree. The per cent inhibition was not statistically
different in any of these groups. While there was some degree of
inhibition with these MPO-ANCA IgG, none of the patients
was significantly different from that observed for the control of
IgG patients.
DISCUSSION
ANCA have been found in the circulation of patients with a
spectrum of disease ranging from systemic vasculitis (e.g.
microscopic polyarteritis nodosa, Wegener's granulomatosis,
and Churg-Strauss syndrome) to patients with renal-limited
disease (i.e. 'idiopathic' crescentic glomerulonephritis) [4].
These diseases are distinct from immune complex mediated or
anti-glomerular basement membrane antibody-mediated dis-
eases by virtue of the absence of immunoglobulin and comple-
ment deposition in the injured vessels [3].
There are two well described ANCA subtypes. One reacts
with the cytoplasm ofalcohol-fixed neutrophils (C-ANCA), and
is specific for a 29-kD serine protease, usually designated
proteinase 3 [9-12,22]. The second ANCA subtype (P-ANCA)
produces perinuclear staining of alcohol-fixed neutrophils. In
patients with vasculitis and glomerulonephritis, approximately
90% of P-ANCA are specific for MPO, although a very few
patients also have P-ANCA that react with elastase [12,13] or
lactoferrin [23]. The P-ANCA pattern observed by indirect
immunofluorescence microscopy is an artifact of the permeabili-
zation of neutrophils during substrate preparation that results
in the diffusion of primary granule constituents to the nucleus
where they are retained by ionic forces [17].
C-ANCA and P-ANCA, including MPO-ANCA, are cap-
able of activating neutrophils in vitro. The activation process
results in the production of reactive oxygen species, as well as
degranulation [14]. This process is facilitated by cytokines, such
as tumour necrosis factor, which induce translocation ofANCA
antigens (e.g. MPO) to the cell membrane, thus allowing for
interaction with ANCA [14].
In this study, we sought to learn more about the interaction
of human MPO-ANCA with MPO. MPO-ANCA reacted with
native MPO on dot blots, and with a 120-kD band on Western
blots. This 120-kD band is the heterodimer ofMPO [24]. MPO-
ANCA did not react with any of the bands that correspond to
the subunits ofMPO obtained by thermal denaturation [25]. All
15 MPO-ANCA that were tested showed the same patterns of
reactivity when analysed by dot blot and Western blot.
These results suggest that MPO-ANCA react with a confor-
mational antigen or antigens found on the native molecule. This
antigen(s) is resistant to mild denaturation with SDS or
reduction with B-ME, but is destroyed by greater denaturation
(e.g. thermal denaturation). It is not surprising that MPO-
ANCA appear to react with a conformational antigen, since
most determinants recognized by autoantibodies are directed at
epitopes on molecules that are in the appropriate confor-
mational state [15].
Because extracellular MPO may serve as a feedback inhibi-
tor of neutrophil activation [26], we sought to determine
whether MPO inhibited MPO function. No inhibition by MPO-
ANCA of MPO-induced protein iodination was observed,
although the polyclonal anti-MPO antibody, as well as the
mouse monoclonal anti-MPO antibody, were able to inhibit
MPO function. These studies suggest that the activation by
MPO-ANCA of neutrophils is not dependent on the inhibition
of a negative feedback loop.
In conclusion, MPO-ANCA react with MPO conformation-
dependent epitope, and MPO-ANCA binding to this epitope
does not inhibit MPO function.
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